SELLAS Life Sciences Group Inc

SLS NASDAQ Healthcare & Biotech United States US81642T2096
14.32 $
7.34 %

SELLAS Life Sciences Group Inc is a biopharmaceutical company dedicated to the development of immunotherapeutic treatments for a variety of cancers.